Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Sun Pharma may move to Rs 800, says Prakash Gaba

      Prakash Gaba of prakashgaba.com feels that Sun Pharmaceutical may move to Rs 800.

    • Buy HDFC Bank, Dredging Corp; sell Sun Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying HDFC Bank and Dredging Corp and advises selling Sun Pharma.

    • Buy Century Textiles, Bharat Electronics: JK Jain

      JK Jain of Karvy Stock Broking suggests buying Century Textiles and Bharat Electronics.

    • Buy Bharat Electronics, Sun Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises buying Bharat Electronics and Sun Pharma.

    • Buy Ramco Cement, Edelweiss Financial: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Ramco Cement, Edelweiss Financial and Sun Pharmaceutical.

    • Buy KPIT Tech, CONCOR, M&M Financial: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Mahindra & Mahindra Financial Services and KPIT Technologies.

    • Buy PTC India, Karnataka Bank; sell Sun Pharma: Sandeep Wagle

      Sandeep Wagle of powermywealth.com suggests buying PTC India, Karnataka Bank and advises selling Sun Pharma.

    • Lupin may slip to Rs 1250-1300: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com feels that Lupin may slip to Rs 1250-1300.

    • Here is why SP Tulsian is bullish on Marathon Nextgen

      SP Tulsian, sptulsian.com, shares his views on the pharma sector and the real estate space. He also explains why he is bullish on Marathon NextGen.

    • Buy Tech Mahindra, Kajaria Ceramics: Ashish Kyal

      Ashish Kyal of wavesstrategy.com recommends buying Tech Mahindra and Kajaria Ceramics and advises selling Sun Pharma.

    • Buy Sun Pharma at around Rs 750: Mehraboon Irani

      Mehraboon Irani of Nirmal Bang Securities is of the view that one can buy Sun Pharma at around Rs 750.

    • Go long in Sun Pharma, target Rs 795: Aditya Agarwal

      Aditya Agarwal of Way2Wealth Securities recommends going long in Sun Pharma with a target of Rs 795.

    • Buy Infosys on dips, says Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Infosys on dips.

    • Buy JSW Steel, Aurobindo Pharma; sell Jain Irrigation: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying JSW Steel, UPL, Aurobindo Pharma and advises selling Jain Irrigation Systems.

    • Buy Cholamandalam, L&T Fin, Finolex Ind, Raymond: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Cholamandalam Investment, L&T Finance, Muthoot Finance, Finolex Industries and Raymond.

    • Here are a few stocks to watch on May 31

      Here are a few stocks picked up by CNBC-TV18's analysts to keep on your radar for trade today.

    • Buy Reliance Power, HPCL, Sun Pharma, LIC Housing: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one can buy Reliance Power, HPCL, Sun Pharma and LIC Housing Finance.

    • Buy SBI, Sun Pharma, Bank of Baroda: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying State Bank of India, Sun Pharma and Bank of Baroda.

    • Buy Sun Pharma, JSW Steel, Reliance Infra: Sandeep Wagle

      Sandeep Wagle of powermywealth.com advises buying Sun Pharma, JSW Steel and Reliance Infrastructure.

    • Buy Sun Pharma, Zee Entertainment: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma and Zee Entertainment.

    • Buy Indiabulls Housing, CONCOR, M&M Financial: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Indiabulls Housing Finance, CONCOR and Mahindra & Mahindra Financial Services.

    • Buy Biocon; sell Bajaj Finance, Infosys: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Biocon and advises selling Bajaj Finance and Infosys.

    • Infosys, HDFC Bank, Aurobindo are top picks: R Sreesankar

      R Sreesankar, Head Institutional Equities, Prabhudas Lilladher in an interview to CNBC-TV18 shared his rationale for picking Infosys, HDFC Bank, Aurobindo Pharma, Jubilant Life and Glenmark as his top picks.

    • Buy Sun Pharma 820 Call, TCS 2600 Call: VK Sharma

      VK Sharma of HDFC Securities is of the view that one may buy Sun Pharmaceutical Industries 820 Call and Tata Consultancy Services 2600 Call.

    • Prefer Srikalahasthi Pipes: Prakash Diwan

      Prakash Diwan of prakashdiwan.in is of the view that one may prefer Srikalahasthi Pipes.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347